Closed · RFA-FD-12-005 · CFDA 93.103 · Discretionary

Misuse and Abuse of DEA Schedule II-V Opioid Analgesic Drugs: Researching Strategies to Ensure Safe Use and Reduce Preventable Harm (U01)

Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.

up to $75K
Award range
Closed
Status
May 9, 2012
Close date
4
Expected awards

The verdict

Misuse and Abuse of DEA Schedule II-V Opioid Analgesic Drugs: Researching Strategies to Ensure Safe Use and Reduce Preventable Harm (U01) is a closed discretionary listing from Food and Drug Administration that offered Up to $75,000 across 4 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.

up to $75K
award range
Closed
application status
4
expected awards
93.103
CFDA program

Archived opportunity record

Misuse and Abuse of DEA Schedule II-V Opioid… is closed (last close May 9, 2012). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed May 9, 2012

Posted Mar 15 Closes May 9

Est. Total Funding

$300,000

Expected Awards

4

Instrument

Cooperative Agreement

Description

As part of the FDA's Safe Use Initiative's mission to seek solutions to reduce preventable harm from suboptimal use (e.g., misuse and abuse) of medications, CDER is seeking to support a limited number of research projects aimed at examining interventions and strategies that can be used by prescribers to increase the safe use and reduce misuse and abuse of opioid analgesic drugs. This funding opportunity announcement (FOA), issued by the FDA, will provide resources for research to further define the knowledge, attitudes, and behaviors that lead to inappropriate use and abuse of opioid analgesics; to research and implement strategies impacting inappropriate use and abuse of these drugs; and subsequently reduce the preventable harm, morbidity and mortality caused by Schedule II-V prescription opioid analgesic drugs. Inappropriate use and abuse can include but is not limited to prescriber misprescribing or over-prescribing and patient or citizen use of a drug in a manner that is not its intended use (e.g., non-medical use), dose or schedule, or inappropriate or inadvertent mixing of multiple drugs that interact. The goal of this FOA is to increase the body of knowledge around effective strategies that can reduce misuse and abuse of prescription opioid analgesic drugs, and are applicable in a variety of settings and can be easily sustained by the people who will implement and use the strategies.

Wide-open applicant board · 14 Grants.gov doors

Misuse and Abuse of DEA Schedule II-V Opioid… prints 14 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +10 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Consumer Protection · Food and Nutrition · Health · Income Security and Social Services (CP;FN;HL;IS). 54 other Food and Drug Administration listings share this eligibility-code string (11% of 482).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Stephanie D. Bogan Grants Management Specialist

What to do next

Misuse and Abuse of DEA Schedule II-V Opioid… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
  • Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
  • Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants